Volume$131.7K
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Found an error or inaccuracy?
Help make the event more accurate — suggest a correction, appeal the decision, or report a problem.
Related events
Which parties will be part of the next government of Romania?
68%
PSD
How many ships transit Bab el-Mandeb Strait week of October 12?
30%
170-189
How many ships transit the Strait of Hormuz week of October 12?
24%
30-34
Event news
All newsNo news for this event yet
Suggest news — we'll link it to the event and show it here after moderation.
